Last reviewed · How we verify
Antioxidant therapies — Competitive Intelligence Brief
marketed
Antioxidant agent
Multiple (Cardiovascular, Neurology, Oncology supportive care, General)
Small molecule
Live · refreshed every 30 min
Target snapshot
Antioxidant therapies (Antioxidant therapies) — Mansoura University Hospital. Antioxidant therapies work by neutralizing reactive oxygen species and free radicals to reduce oxidative stress and cellular damage.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Antioxidant therapies TARGET | Antioxidant therapies | Mansoura University Hospital | marketed | Antioxidant agent | ||
| Liposomal curcumin | Liposomal curcumin | University of Florida | marketed | Natural product derivative; anti-inflammatory/antioxidant agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antioxidant agent class)
- Mansoura University Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Antioxidant therapies CI watch — RSS
- Antioxidant therapies CI watch — Atom
- Antioxidant therapies CI watch — JSON
- Antioxidant therapies alone — RSS
- Whole Antioxidant agent class — RSS
Cite this brief
Drug Landscape (2026). Antioxidant therapies — Competitive Intelligence Brief. https://druglandscape.com/ci/antioxidant-therapies. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab